Monthly Archives: November 2009
Hot Topics at HBA
The 2009 Healthcare Businesswomen’s Association leadership conference is officially underway in sunny California. Last night, festivities got underway with a welcome reception for attendees followed by a “Taste of San Francisco,” which featured lively entertainment and regional cuisine.
I had the opportunity to catch up with a few seasoned participants who are widely known throughout the [...]
Past Performance Is No Indication Of Future Results
Sponsored Guest blog post by Patrick Homer, Life Science Practice Principal, SAS.
The lingo that accompanies every financial investment prospectus has never been more apt in our post meltdown economy. Yet when it comes down to directing the billion dollar investments in sales and marketing spends, the pharma industry has been firmly entrenched in this belief. [...]
Posted in Guest Blog, Strategy Tagged business, Industry, Investing, Investment, Marketing, Model, Services, Technology Leave a comment
When Big Pharma Leaves Town
Image via Wikipedia
Wall Street smiles when a drug company gets with the program by “restructuring” and “rightsizing”—cutting costs through headline-grabbing layoffs. But for Main Street, the story of hundreds or thousands of sales reps, say, and researchers getting kicked to the curb is quite different.
The two gi-normous mergers that closed in the past month offer [...]
Posted in Strategy Tagged Eminent domain, New Jersey, New London, New York Times, Real estate, Thames River, United States Supreme Court, Wall Street 2 Comments
Google Unveils New Pharma Ads
Image via CrunchBase
Google just showed off mockups of its fancy new pharma ads at FDA’s social media hearing, on November 12. A few months back, the big G mentioned that it was working on ads to appease both pharmaceutical marketers and FDA, but this is the first time most people got to lay eyes on [...]
Posted in Strategy Tagged Advertising, Food and Drug Administration, Google, Health care, Search, Search Engines, Uniform Resource Locator, Yahoo 2 Comments

Q&A With Renee Tannenbaum